Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Giulia Massaro
Observed name:
G. Massaro
Institutions:
Azienda Ospedaliero-Universitaria Careggi,
Hospital Universitario Fundación Jiménez Díaz,
University of Florence
Observed institutions:
Azienda Ospedaliero-Universitaria Careggi,
Hospital Universitario Fundación Jiménez Díaz,
Instituto de Investigación Sanitaria Fundación Jiménez Díaz,
University of Florence
ORCID:
0009-0008-7177-2717
Observed ORCID:
0009-0008-7177-2717
OpenAlex ID:
A5117333675
Immune checkpoint inhibitors in the first-line treatment of esophageal squamous cell carcinoma: Minireview for a big shift
2025
·
Giulia Massaro
, Alexandra Paulet
, et al.
·
World Journal of Gastrointestinal Oncology
·
3
Microbiome dysbiosis and KRAS-driven tumorigenesis in pancreatic cancer: implications for immune checkpoint inhibitors efficacy
2025
·
Giulia Massaro
, Daniele Lavacchi
, et al.
·
Journal of the National Cancer Center
·
2
Beneath the surface of colorectal cancer: Unmasking the evolving nature of (Neo)RAS
2025
·
Giulia Massaro
, Jacopo Venturini
, et al.
·
Critical Reviews in Oncology/Hematology
·
2
Everolimus as maintenance therapy in advanced neuroendocrine neoplasms: results from the MAVERIC phase II trial
2025
·
Lorenzo Antonuzzo
, Daniele Lavacchi
, et al.
·
The Oncologist
·
1
Baseline body mass index (BMI) impact in advanced cholangiocarcinoma (CCA) treated with chemo-immunotherapy (Chemo-IO): Overall, sex-based, and site-specific analyses.
2026
·
Giulia Massaro
, Giulia Petroni
, et al.
·
Journal of Clinical Oncology
Impact of ACE inhibitors (ACEi) and angiotensin receptor blockers (ARB) on outcomes in hepatocellular carcinoma treated with atezolizumab–bevacizumab.
2026
·
Costanza Winchler
, Fabio Marra
, et al.
·
Journal of Clinical Oncology
First-line immune checkpoint inhibitors in elderly colorectal cancer patients in the real world: Retrospective phase of the multicenter ELDER CRC trial.
2026
·
Martina Cassaniti
, Alessandra Boccaccino
, et al.
·
Journal of Clinical Oncology
Deciphering the heterogeneity and cellular interactions of cancer-associated fibroblasts in extrahepatic cholangiocarcinoma by spatial transcriptomics.
2026
·
Giulia Petroni
, Simone Romagnoli
, et al.
·
Journal of Clinical Oncology
Abstract 5425: Clinical and genomic characterization of biliary tract tumors (BTT) with ARID1A mutations: A case-control study.
2026
·
Giulia Massaro
, Manuel Pedegral
, et al.
·
Cancer Research
Abstract 6046: Spatial transcriptomic profiling of cancer-associated fibroblast niches in extrahepatic cholangiocarcinoma
2026
·
Giulia Petroni
, Simone Romagnoli
, et al.
·
Cancer Research
291P Spatial transcriptomics of extrahepatic cholangiocarcinoma unravels immunosuppressive features of cancer-associated fibroblasts
2025
·
G. Petroni
, S. Romagnoli
, et al.
·
Annals of Oncology
NUC-1031 in aBTC: A cautionary tale in accelerated drug development
2025
·
Giulia Massaro
, Lorenza Rimassa
, et al.
·
Journal of Hepatology
Show more works
View as search
Works count:
12
Citation count:
8
H-index:
2
I10-index:
Year
Topic
Type